Posted by mastermind on 4th of Mar 2024 at 01:41 pm
After focusing on selling earlier, I've done some dip buying
since. The best of these is probably FOUR, which retested its
breakout level at its 9 EMA. I was happy to buy it back there after
selling nearly at its peek just two days ago. The most risky is
RVSN, which I mentioned might find support in the low 2's, and I
hope it does because that's there I bought it. Aside from those, a
re-starter position in ACMR, buying back into SOUN, a couple of
strong junior biotechs revisiting short term MA's in EQ and SANA,
and a maybe too stubborn add of ANY at its 200 SMA. Obviously
counting on this rally not being over yet, but not adding any big
cap tech right now.
Newsletter
Subscribe to our email list for regular free market updates
as well as a chance to get coupons!
After focusing on selling earlier,
Posted by mastermind on 4th of Mar 2024 at 01:41 pm
After focusing on selling earlier, I've done some dip buying since. The best of these is probably FOUR, which retested its breakout level at its 9 EMA. I was happy to buy it back there after selling nearly at its peek just two days ago. The most risky is RVSN, which I mentioned might find support in the low 2's, and I hope it does because that's there I bought it. Aside from those, a re-starter position in ACMR, buying back into SOUN, a couple of strong junior biotechs revisiting short term MA's in EQ and SANA, and a maybe too stubborn add of ANY at its 200 SMA. Obviously counting on this rally not being over yet, but not adding any big cap tech right now.